# NVIGEN Inc.: Research, San Jose, United States

> NVIGEN Inc.: NVIGEN Inc. is a nanobiotechnology company specializing in multifunctional, molecularly engineered nanoparticles for biomedical and...

Source: https://millionrounds.com/startup/nvigen-inc (Millionrounds; every figure on the page links to its filing or article)

United States · [Research startup](https://millionrounds.com/companies)

# NVIGEN Inc.

NVIGEN Inc. is a nanobiotechnology company specializing in multifunctional, molecularly engineered nanoparticles for biomedical and personalized medicine applications.

Email

Funding reported Last round: Series B

Research San Jose, United States

Follow NVIGEN Inc. and see its new rounds in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Fstartup%2Fnvigen-inc)

Company summary

- **Founded:** 2011 15 years old
- **Team:** 12 11 to 50 people
- **Funding reported:** $1.1M in dollars
- **Last round:** Series B Mar 2014

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for NVIGEN Inc. has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About NVIGEN Inc.

NVIGEN Inc. is a nanobiotechnology company specializing in multifunctional, molecularly engineered nanoparticles for biomedical and personalized medicine applications.

The company develops advanced nanoparticle-based technologies for sequencing, liquid biopsy, diagnostics, imaging, and targeted delivery, with a strong focus on cancer profiling and precision medicine. Its core platform features proprietary nanoparticle-imaging-delivery technology and a range of branded product lines. These include MagVigenTM magnetic nanoparticles for DNA capture and purification, MyQuVigenTM combinations for imaging and detection, MaxVigenTM multifunctional nanobeads for targeted delivery, and AuVigenTM gold nanoparticles for various sensing and therapeutic applications. NVIGEN also provides customizable nanoparticle services and ready-to-use reagents for diverse applications, including next-generation sequencing and liquid biopsy workflows. The company promotes its NVIGEN XTM precision medicine and cancer biomarker profiling assays, which include tests designed to predict cancer recurrence and guide personalized therapy. NVIGEN's technologies are utilized by researchers globally, supporting advancements in biomedical research, diagnostics, gene and cell therapy, and drug delivery.

## What company datasets say NVIGEN Inc. raised

Funding, as reported

Reported in all **$1.1M** in dollars

Rounds **3**

Last round **Series B**

Last round size **$1.1M**

Last round date **Mar 2014**

Investors listed **2**

## Funding filed with regulators

NVIGEN Inc. filed one raise, $1.1M in all. Filings say how much was sold and to how many investors; they never name the investors.

- Mar 2014 **$1.1M** 13 investors equity of $1.5M offered SEC Form D

## Founders and team

From the SEC filings it signed: 2 on the team.

- **Aihua Fu** Executive Officer, Director, Promoter i
- **Xiangdong Jin** Executive Officer i

On the board, as filed i *Guoliang Yu*

## The company, in detail

What they build

Known for

health care liquid biopsy dna size selection molecular diagnostics spatial & temporal sequencing biotechnology research distribution manufacturing cancer recurrence prediction cfdna extraction drug delivery biomarker detection in vivo drug targeting nanopipette technology hospital & health care multimodal biomarker profiling

Built with from their website

Google Cloud Hosting Microsoft Exchange Microsoft 365 Apps & Services GoDaddy Domains Mailchimp Mandrill Microsoft Exchange Online Microsoft 365 Outlook Microsoft Email Providers GoDaddy Hosting

+1 more

Google Search Console

- **Sector:** Research
- **Industry code:** NAICS 541714, 325413, 339112, SIC 3824
- **Region:** California
- **Revenue:** $3.5M a year, as listed
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/nvigen)

## Research in United States

Startups like it

- [**OpenAI** San Francisco · founded 2011 *Raised*](https://millionrounds.com/company/openai)
- [**Retro Biosciences** Redwood City · founded 2021 *Raised*](https://millionrounds.com/company/retro-biosciences)
- [**NewLimit** South San Francisco · founded 2022 *Raised*](https://millionrounds.com/company/newlimit)
- [**Pathos** New York · founded 2022 *Raised*](https://millionrounds.com/company/pathos)
- [**Colossal Biosciences** Dallas · founded 2021 *Raised*](https://millionrounds.com/company/colossal-biosciences)
- [**Beeline Medicines** Stamford · founded 2025 *Raised*](https://millionrounds.com/company/beeline-medicines)
- [**Oratomic** South Pasadena *Raised*](https://millionrounds.com/company/oratomic)
- [**Element Biosciences** San Diego · founded 2017 *Raised*](https://millionrounds.com/company/element-biosciences)

## Is this your company?

Add your raise, your deck and your story, and put NVIGEN Inc. in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)